Optimization of vancomycin dosing in very low-birth-weight preterm neonates.

about

Adverse consequences of neonatal antibiotic exposure

P2860

Q35926313-81C05E99-17DA-40F6-970B-BCA40114A13D

P2860

Optimization of vancomycin dosing in very low-birth-weight preterm neonates.

Item

http://www.wikidata.org/entity/Q35564749

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Optimization of vancomycin dosing in very low-birth-weight preterm neonates.

@ast

Optimization of vancomycin dosing in very low-birth-weight preterm neonates.

@en

type

Item

label

Optimization of vancomycin dosing in very low-birth-weight preterm neonates.

@ast

Optimization of vancomycin dosing in very low-birth-weight preterm neonates.

@en

prefLabel

Optimization of vancomycin dosing in very low-birth-weight preterm neonates.

@ast

Optimization of vancomycin dosing in very low-birth-weight preterm neonates.

@en

P1476

Optimization of vancomycin dosing in very low-birth-weight preterm neonates.

@en

P2093

Christine B Teng

http://www.w3.org/2001/XMLSchema#string

Jena Koshaish

http://www.w3.org/2001/XMLSchema#string

Kent R Johnson

http://www.w3.org/2001/XMLSchema#string

Kevin K Graner

http://www.w3.org/2001/XMLSchema#string

Ritu Banerjee

http://www.w3.org/2001/XMLSchema#string

Theresa Madigan

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Vancomycin: pharmacokinetics and administration regimens in neonates.

Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance

Clinical pharmacokinetics of vancomycin in the neonate: a review

Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Constant rate infusion of vancomycin in premature neonates: a new dosage schedule

Pharmacokinetics and dose requirements of vancomycin in neonates.

Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.

The influences of renal function and maturation on vancomycin elimination in newborns and infants.

Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss.

P304

83-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1055/S-0034-1376183

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24839147

http://www.w3.org/2001/XMLSchema#string

P932

4418186

http://www.w3.org/2001/XMLSchema#string

Optimization of vancomycin dosing in very low-birth-weight preterm neonates.

about

P2860

P2860

Optimization of vancomycin dosing in very low-birth-weight preterm neonates.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932